Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Supercomputing (21)
- Advanced Manufacturing (22)
- Biological Systems (1)
- Biology and Environment (26)
- Building Technologies (1)
- Clean Energy (83)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (6)
- Materials (29)
- Materials for Computing (4)
- National Security (4)
- Neutron Science (17)
- Nuclear Science and Technology (6)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (5)
- (-) Biomedical (17)
- Advanced Reactors (1)
- Artificial Intelligence (36)
- Big Data (20)
- Bioenergy (9)
- Biology (11)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (5)
- Climate Change (17)
- Computer Science (95)
- Coronavirus (14)
- Critical Materials (3)
- Cybersecurity (8)
- Decarbonization (5)
- Energy Storage (8)
- Environment (21)
- Exascale Computing (24)
- Frontier (29)
- Fusion (1)
- Grid (5)
- High-Performance Computing (40)
- Isotopes (2)
- Machine Learning (14)
- Materials (15)
- Materials Science (16)
- Mathematics (1)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (8)
- Net Zero (1)
- Neutron Science (13)
- Nuclear Energy (4)
- Partnerships (1)
- Physics (8)
- Polymers (2)
- Quantum Computing (19)
- Quantum Science (24)
- Security (5)
- Simulation (15)
- Software (1)
- Space Exploration (3)
- Summit (43)
- Sustainable Energy (10)
- Transportation (6)
Media Contacts
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.